Facial Injectables Market Size, Share, and Growth Analysis

Global Facial Injectables Market

Facial Injectables Market By Product and Services (Systems, Disposables), By Source Type (Insourced Monitoring, Outsourced Monitoring), By Application (Spinal Surgery, Neurosurgery), By Region -Industry Forecast 2024-2031


Report ID: SQMIG35I2287 | Region: Global | Published Date: October, 2024
Pages: 157 |Tables: 100 |Figures: 76

Format - word format excel data power point presentation

Facial Injectables Market Insights

Facial Injectables Market size was valued at USD 11.31 Billion in 2023 and is poised to grow from USD 12.67 Billion in 2024 to USD 31.37 Billion by 2032, growing at a CAGR of 12.00% during the forecast period (2025-2032).

The demand for facial injectables has increased in recent years due to the increased consumer focus on physical appearance. The presence of many common signs of aging has also led to a global demand for facial injectables. Signs of aging like skin wrinkles and sagging due to low facial elasticity, dark spots etc. are common concerns that drive interest in anti-aging and skincare products. The beauty industry has responded with a range of innovative products and treatments aimed at addressing these visible effects of aging. 

Minimally invasive surgery is rapidly replacing invasive surgery. According to the American Society of Plastic Surgeons (ASPS), approximately 18 million minimally invasive surgical and cosmetic procedures were performed in the US. in 2020, out of which nearly 16 million products were minimally invasive. Thus, the increasing adoption of minimally invasive surgeries, coupled with the availability of a wide range of such treatment options, is driving market growth. 

Well-established major players like Allergan, Sinclair Pharma, Galderma with a comprehensive injectable supplement portfolio are treating a wide range of skin indications such as wrinkles, pigmentation, plumping lips, scars, facial fullness. Increased visibility on social media, increasing effectiveness and acceptance of facial massages and growing desire to look beautiful and youthful in society is expected to drive the facial injectables industry during the forecast period.

US Facial Injectables Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2025-2032

Global Market Size

USD 11.31 Billion

Largest Segment

MedSpas

Fastest Growth

Dermatology Clinics

Growth Rate

12.00% CAGR

Global Facial Injectables Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Facial Injectables Market Segments Analysis

Global Facial Injectables Market is segmented by Product, Application, End-use and region. Based on component, the market is segmented into Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-lactic Acid (PLLA), and Others. Based on Application, the market is segmented into Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, and Others. Based on End-use, the market is segmented into MedSpas, Dermatology Clinics, Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa. 

Analysis by Component 

The collagen & PMMA microspheres segment is dominating the market. The collagen & PMMA microspheres segment is important for patients seeking the long-term, systemic improvement. PMMA (polymethyl methacrylate) microspheres are synthetic materials that provide durability and uniform size. But collagen injections help restore firmness and structure to the skin. PMMA microspheres provide the longer lasting results compared to hyaluronic acid. PMMA essentially remains on the skin as a fixed implant, offering a permanent or semi-permanent alternative. PMMA-based fillers make facial contours more pronounced, providing adequate tone and strong support. This is ideal for elderly patients with extremely sensitive skin or reduced facial muscle tone.  

As per facial injectables market analysis, dermatology clinics is the fastest growing segment. Dermatology clinics remain a reliable and powerful option for injectables, especially among consumers who prioritize safety, knowledge and medical guidance. Dermatologists are skin health experts, and many patients choose these clinics because of the increased trust and assurance that comes with medical supervision. Dermatology clinics tend to attract patients with sensitive skin that have a strong need for or a high level of flexibility and precision in their injections. Dermatology clinics have board-licensed dermatologists and certified physicians, giving the sufferers peace of mind approximately treatment protection. Many purchasers, especially elderly sufferers or those with sensitive pores and skin pick injections in a medical setting where complications can be treated effectively. 

Analysis by End-Use 

Based on end-use, the MedSpas segment dominated the market and accounted for the most important revenue percentage of 48.8% in 2023. Medspa is a facility wherein beauty services are supplied underneath the supervision of a certified doctor. All non-invasive treatments are executed in these facilities, which consist of facial injections, non-invasive body contouring, pores and skin rejuvenation, and laser remedies through experienced experts. These centers comply with all the regulatory guidelines and requirements set with the aid of the authorities and need to be mandatorily owned by using a health practitioner. MedSpas are increasingly adopting novel treatment structures to gain a higher market share. The employees in medspas need to have a license in aesthetics as well as scientific education. 

As per facial injectables market outlook, the outsourced monitoring segment is expected to grow at the highest CAGR of 8.13% during the forecast period for reasons such as cost and special services. The ongoing development and evolution of IONM technology enhances its capabilities. Outsourcing these services allows the hospitals to avoid the financial burden associated with purchasing and maintaining expensive equipment. In addition, training neurologists can be expensive and time-consuming, as they must have access to the latest technology. These trends are driving dramatic changes to the outsourcing of IONM systems. Also, through outsourcing, surgical teams can focus on their core responsibilities by relying on qualified staff to manage arthroscopy. 

Global Facial Injectables Market By End-Use (%)

To get detailed analysis on other segments, Request For Free Sample Report

Facial Injectables Market Regional Insights

As per facial injectables market forecast, North America dominated and accounted for the highest revenue growth of 40.1% in 2023. North America plays crucial roles in the global facial injectables market, both in terms of demand and growth dynamics. This increase is driven via the old populace in the US. and Canada is anticipated to reinforce the demand for injectables. North America, particularly the United States, is the largest market for facial injectables, driven by high disposable incomes, widespread cultural acceptance of cosmetic enhancements, and a well-established healthcare infrastructure. The region leads in both the development and adoption of new injectable treatments, including botulinum toxin injections (like Botox) and dermal fillers. 

The Asia-Pacific region is the fastest growing segment in the market. Asia-Pacific region especially South Korea, Japan, China, India, is growing due to increasing disposable income, and growing middle class. In many Asian countries, maintaining and adhering to a youthful look beauty standards are highly regarded, especially in urban areas. Things like facial contouring with dermal fillers are particularly popular, and social media has accelerated the appetite for injectables among young consumers. Asia-Pacific is estimated to post the highest CAGR of the market at 15.7% during the forecast period. The region is supported by countries such as India, Australia and South Korea. Growing awareness of body care in these developing countries is expected to play an important role in boosting the demand for facial injectables.

Global Facial Injectables Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Facial Injectables Market Dynamics

Drivers 

Growing Demand for Non-surgical Cosmetic Products 

  • Increasing demand for over-the-counter cosmetic products is a key driver for the facial injectables market growth. Consumers are looking for options that have improved their appearance without the risks, downtime and costs associated with traditional plastic surgery. Botox and other topical drugs and facial injections, including neuromodulators, offer less invasive ways to reduce wrinkles, add volume and enhance facial contours. This change never manifested in different age groups, with younger people opting for preventative treatment and older individuals seeking to look younger.  

Advances In Injection Technology and Formulation 

  • Technological advances have transformed the facial injectables market, making products safer, more durable and more effective. Innovations in the fillers, such as hyaluronic acid (HA) with advanced cross-linking techniques, fillers, combine now offering long-lasting natural-like results that last longer. Additionally, the development of softer, more malleable fillers enables the proper contouring, permitting practitioners to treat diverse areas of the face with extra accuracy and customization. 

Restraints 

High Cost of Injectables 

  • The cost of facial injectables remains prohibitive, especially for middle income earners and young people who find these treatments financially prohibitive. Injectables are often considered a luxury or treatment option of the product's treatment area. Many injections provide short-term results, patients must schedule follow-up treatments, increasing financial commitment. Lack of insurance coverage for cosmetic procedures also limits access, especially in areas where consumers have limited disposable income. As a result, cost remains a constraint, especially in markets where the public is sensitive to prices. 

Risk of Adverse Effects and Complications 

  • Despite advances in product safety and acupuncture techniques, the risks of acupuncture carry risks that may deter some users. Adverse effects potential side effects range from mild reactions such as inflammation and bruising to more serious complications such as tissue damage, skin damage, and infection. Fear of adverse reactions to online chats and information heightened media coverage can discourage individuals seeking massage therapy.

Request Free Customization of this report to help us to meet your business objectives.

Facial Injectables Market Competitive Landscape

The facial injectables market is highly competitive, with global pharmaceutical companies, beauty specialties, and new entrants aiming to capture new products and strategic market share. The competition is primarily driven by the need for innovative, safe, and long-lasting products. The need to develop products that cater to a more diverse customer base, key players although focus on the research and development, regulatory compliance and targeted marketing strategies strengthen their position in the market. The landscape is dominated by established companies such as Allergan, Galderma, Merz Pharmaceuticals, Rivens Therapeutics, and many regional players using local competition. 

Top Players in Facial Injectables Market

  • Ispen (France) 
  • Abbvie (US) 
  • Medytox Inc. (South Korea) 
  • Merz GmbH and Co. KGaA (Germany) 
  • Revance Therapeutics, Inc. (US) 
  • Galderma (Switzerland) 
  • Sinclair Pharma (UK) 
  • Allergan Aesthetics (a subsidiary of AbbVie) (US) 
  • Hugel, Inc. (South Korea) 
  • Sientra, Inc. (US) 
  • Revance Therapeutics, Inc. (US) 
  • Evolus, Inc. (US) 
  • Medytox Inc. (South Korea) 
  • Hugel, Inc. (South Korea) 
  • AptarGroup, Inc. (US) 
  • Ipsen S.A. (France) 
  • Galderma S.A. (Switzerland) 
  • Revanesse (Canada) 
  • Merz North America (US) 
  • Suneva Medical, Inc. (US) 
  • Aesthetic Medical International Holdings Group (China) 
  • Neauvia (Switzerland)

Facial Injectables Market Recent Developments

  • In August 2022, Allergan Healthcare India launched Juvederm VOLUX, an injectable treatment aimed at lifting and plumping the face, under the Allergan Aesthetics collaboration. 
  • In February 2022, Merz Aesthetics launched Radiesse as the first and only cosmetic procedure to improve moderate to severe jawbone loss.  
  • In September 2023, AbbVie Inc. announced positive results from its Phase III clinical study assessing the effectiveness of Onabotulinum ToxinA (BOTOX Cosmetic) in the treatment of moderate to severe prominent platysma. This will lift the exposure of vertical neck lines, reduce and improve the nasal lines. 

Facial Injectables Key Market Trends

Facial Injectables Market SkyQuest Analysis

SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.   

According to SkyQuest analysis, the facial injectables market is growing rapidly, driven by increasing demand for less invasive cosmetic products. Continuous technological advancements that improve the safety and effectiveness of massage products are highly effective, but the high cost of treatment and the risk of side effects pose challenges for larger market adoption. Key trends, such as the increasing use of preventive medicine among young people and the expanding male population in emerging markets, highlight consumer preferences and movement of market opportunities. As a result, the facial injectables market is poised for further growth with innovation, supported by innovation, diversification of the consumer base, and greater acceptance of aesthetic enhancements.

Report Metric Details
Market size value in 2023 USD 11.31 Billion
Market size value in 2032 USD 31.37 Billion
Growth Rate 12.00%
Base year 2024
Forecast period 2025-2032
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-lactic Acid (PLLA), Others
  • Application
    • Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Others
  • End-use
    • MedSpas, Dermatology Clinics, Hospitals
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Ispen (France) 
  • Abbvie (US) 
  • Medytox Inc. (South Korea) 
  • Merz GmbH and Co. KGaA (Germany) 
  • Revance Therapeutics, Inc. (US) 
  • Galderma (Switzerland) 
  • Sinclair Pharma (UK) 
  • Allergan Aesthetics (a subsidiary of AbbVie) (US) 
  • Hugel, Inc. (South Korea) 
  • Sientra, Inc. (US) 
  • Revance Therapeutics, Inc. (US) 
  • Evolus, Inc. (US) 
  • Medytox Inc. (South Korea) 
  • Hugel, Inc. (South Korea) 
  • AptarGroup, Inc. (US) 
  • Ipsen S.A. (France) 
  • Galderma S.A. (Switzerland) 
  • Revanesse (Canada) 
  • Merz North America (US) 
  • Suneva Medical, Inc. (US) 
  • Aesthetic Medical International Holdings Group (China) 
  • Neauvia (Switzerland)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Facial Injectables Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Facial Injectables Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Facial Injectables Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Facial Injectables Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Facial Injectables Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Facial Injectables Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Facial Injectables Market size was valued at USD 11.31 Billion in 2023 and is poised to grow from USD 12.67 Billion in 2024 to USD 31.37 Billion by 2032, growing at a CAGR of 12.00% during the forecast period (2025-2032).

The facial injectables market is highly competitive, with global pharmaceutical companies, beauty specialties, and new entrants aiming to capture new products and strategic market share. The competition is primarily driven by the need for innovative, safe, and long-lasting products. The need to develop products that cater to a more diverse customer base, key players although focus on the research and development, regulatory compliance and targeted marketing strategies strengthen their position in the market. The landscape is dominated by established companies such as Allergan, Galderma, Merz Pharmaceuticals, Rivens Therapeutics, and many regional players using local competition.  'Ispen (France) ', 'Abbvie (US) ', 'Medytox Inc. (South Korea) ', 'Merz GmbH and Co. KGaA (Germany) ', 'Revance Therapeutics, Inc. (US) ', 'Galderma (Switzerland) ', 'Sinclair Pharma (UK) ', 'Allergan Aesthetics (a subsidiary of AbbVie) (US) ', 'Hugel, Inc. (South Korea) ', 'Sientra, Inc. (US) ', 'Revance Therapeutics, Inc. (US) ', 'Evolus, Inc. (US) ', 'Medytox Inc. (South Korea) ', 'Hugel, Inc. (South Korea) ', 'AptarGroup, Inc. (US) ', 'Ipsen S.A. (France) ', 'Galderma S.A. (Switzerland) ', 'Revanesse (Canada) ', 'Merz North America (US) ', 'Suneva Medical, Inc. (US) ', 'Aesthetic Medical International Holdings Group (China) ', 'Neauvia (Switzerland)'

Increasing demand for over-the-counter cosmetic products is a key driver for the facial injectables market growth. Consumers are looking for options that have improved their appearance without the risks, downtime and costs associated with traditional plastic surgery. Botox and other topical drugs and facial injections, including neuromodulators, offer less invasive ways to reduce wrinkles, add volume and enhance facial contours. This change never manifested in different age groups, with younger people opting for preventative treatment and older individuals seeking to look younger.  

Increased Popularity of “Baby Botox” and Preventive Treatments: A growing facial injectables market trend is “baby Botox” and the growing popularity of preventative therapies among younger consumers. Instead of waiting for wrinkles and other signs of aging to appear, consumers in their 20s and 30s are increasingly opting for subtle, preventive treatments. Baby Botox contains low levels of botulinum toxin to achieve a natural smooth appearance without “cold” facial features. This trend has been fueled by social media and a broader cultural shift towards beauty enhancement as a form of self-care.  

As per facial injectables market forecast, North America dominated and accounted for the highest revenue growth of 40.1% in 2023. North America plays crucial roles in the global facial injectables market, both in terms of demand and growth dynamics. This increase is driven via the old populace in the US. and Canada is anticipated to reinforce the demand for injectables. North America, particularly the United States, is the largest market for facial injectables, driven by high disposable incomes, widespread cultural acceptance of cosmetic enhancements, and a well-established healthcare infrastructure. The region leads in both the development and adoption of new injectable treatments, including botulinum toxin injections (like Botox) and dermal fillers. 

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Facial Injectables Market
Facial Injectables Market

Report ID: SQMIG35I2287

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE